Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × UNKNOWN × Nasopharyngeal Carcinoma × Clear all

Phase

Phase 3 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 20 INDUSTRY 6 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Colorectal Neoplasms 2 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

anlotinib 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

ChineseAMS

Phase 1/2 Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡